<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;ff=20250409061434&amp;fc=20230708114047&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;ff=20250409061434&amp;fc=20230708114047&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Wed, 09 Apr 2025 10:14:37 +0000</lastbuilddate>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Detection of large areas of thin-cap fibroatheroma in a recurrent STEMI patient using a novel artificial intelligence algorithm: moving from 2D to 3D</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40197833/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehaf189. doi: 10.1093/eurheartj/ehaf189. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40197833/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40197833</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf189>10.1093/eurheartj/ehaf189</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40197833</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Thijs J Luttikholt</dc:creator>
<dc:creator>Jos Thannhauser</dc:creator>
<dc:creator>Niels van Royen</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Detection of large areas of thin-cap fibroatheroma in a recurrent STEMI patient using a novel artificial intelligence algorithm: moving from 2D to 3D</dc:title>
<dc:identifier>pmid:40197833</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf189</dc:identifier>
</item>
<item>
<title>Mode of revascularization for ischaemic cardiomyopathy: comparing apples with oranges?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40197821/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehaf201. doi: 10.1093/eurheartj/ehaf201. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40197821/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40197821</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf201>10.1093/eurheartj/ehaf201</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40197821</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Kayla Chiew</dc:creator>
<dc:creator>Shayna Chotai</dc:creator>
<dc:creator>Rasha Al-Lamee</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Mode of revascularization for ischaemic cardiomyopathy: comparing apples with oranges?</dc:title>
<dc:identifier>pmid:40197821</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf201</dc:identifier>
</item>
<item>
<title>SiglecF+ neutrophils link periodontitis to impaired post-myocardial infarction repair</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40197802/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehaf165. doi: 10.1093/eurheartj/ehaf165. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40197802/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40197802</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf165>10.1093/eurheartj/ehaf165</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40197802</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Hatim Boughanem</dc:creator>
<dc:creator>Andrea Herrero-Cervera</dc:creator>
<dc:creator>Oliver Soehnlein</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>SiglecF+ neutrophils link periodontitis to impaired post-myocardial infarction repair</dc:title>
<dc:identifier>pmid:40197802</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf165</dc:identifier>
</item>
<item>
<title>A microbiota pattern associated with cardiovascular events in secondary prevention: the CORDIOPREV study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40197788/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: These results reinforce the relationship between intestinal microbiota and CVD and suggest that a microbiota profile is associated with MACE in CHD patients, in addition to higher endotoxaemia.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehaf181. doi: 10.1093/eurheartj/ehaf181. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Preventing new cardiovascular events in patients with established cardiovascular disease (CVD) is a daunting task for clinicians. Intestinal microbiota may help identify patients at risk, thus improving the strategies of secondary prevention. The aim of this study was to evaluate the baseline differences between the gut microbiota from coronary heart disease (CHD) patients suffering new major adverse cardiovascular events (MACEs) in the following 7 years, compared with CHD patients who did not undergo new MACE in this period, and to build a score associated with the risk of suffering new MACE.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Within the framework of the CORDIOPREV study, a clinical trial that involved 1002 patients with CHD, intestinal microbiota was examined in patients with available faecal samples (n = 679, 132 MACE), through 16S metagenomics on the Illumina MiSeq and Quiime2 software. Lipopolysaccharide (LPS) was measured using limulus amoebocyte lysate test.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Random survival forest identified 10 bacterial taxa with a higher predictive power for MACE incidence. Receiver operating characteristic curves yielded an area under the curve of 65.2% (59.1%-71.3%) in the training set and 68.6% (59.3%-77.9%) in the validation set. The intestinal microbiota risk score was associated with a MACE incidence hazard ratio of 2.01 (95% confidence interval 1.37-3.22). Lipopolysaccharide analysis showed a greater LPS post-prandial fold change in the MACE group (P = .005).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These results reinforce the relationship between intestinal microbiota and CVD and suggest that a microbiota profile is associated with MACE in CHD patients, in addition to higher endotoxaemia.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40197788/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40197788</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf181>10.1093/eurheartj/ehaf181</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40197788</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Javier Arenas-Montes</dc:creator>
<dc:creator>Juan F Alcala-Diaz</dc:creator>
<dc:creator>Helena Garcia-Fernandez</dc:creator>
<dc:creator>Francisco M Gutierrez-Mariscal</dc:creator>
<dc:creator>Alejandro Lopez-Moreno</dc:creator>
<dc:creator>Diego Luque-Cordoba</dc:creator>
<dc:creator>Antonio P Arenas-de Larriva</dc:creator>
<dc:creator>Jose D Torres-Peña</dc:creator>
<dc:creator>Raul M Luque</dc:creator>
<dc:creator>Flavia Prodam</dc:creator>
<dc:creator>Feliciano Priego-Capote</dc:creator>
<dc:creator>Javier Delgado-Lista</dc:creator>
<dc:creator>Jose Lopez-Miranda</dc:creator>
<dc:creator>Antonio Camargo</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A microbiota pattern associated with cardiovascular events in secondary prevention: the CORDIOPREV study</dc:title>
<dc:identifier>pmid:40197788</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf181</dc:identifier>
</item>
<item>
<title>Clinical implications of sex-related differences in severe aortic stenosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40197757/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehaf199. doi: 10.1093/eurheartj/ehaf199. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40197757/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40197757</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf199>10.1093/eurheartj/ehaf199</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40197757</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Kush P Patel</dc:creator>
<dc:creator>Andreas Baumbach</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Clinical implications of sex-related differences in severe aortic stenosis</dc:title>
<dc:identifier>pmid:40197757</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf199</dc:identifier>
</item>
<item>
<title>Ischaemic conditioning: a renaissance with wider perspectives?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40197755/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehaf205. doi: 10.1093/eurheartj/ehaf205. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40197755/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40197755</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf205>10.1093/eurheartj/ehaf205</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40197755</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Gerd Heusch</dc:creator>
<dc:creator>Petra Kleinbongard</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Ischaemic conditioning: a renaissance with wider perspectives?</dc:title>
<dc:identifier>pmid:40197755</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf205</dc:identifier>
</item>
<item>
<title>Copper and cardiac fibrosis: a delicate balance of health and disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40197643/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehaf227. doi: 10.1093/eurheartj/ehaf227. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40197643/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40197643</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf227>10.1093/eurheartj/ehaf227</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40197643</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Julian U G Wagner</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Copper and cardiac fibrosis: a delicate balance of health and disease</dc:title>
<dc:identifier>pmid:40197643</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf227</dc:identifier>
</item>
<item>
<title>Obesity accelerates cardiovascular ageing</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40197620/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>A global obesity pandemic, coupled with an increasingly ageing population, is exacerbating the burden of cardiovascular disease. Indeed, clinical and experimental evidence underscores a potential connection between obesity and ageing in the pathogenesis of various cardiovascular disorders. This is further supported by the notion that weight reduction not only effectively reduces major cardiovascular events in elderly individuals but is also considered the gold standard for lifespan extension, in...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehaf216. doi: 10.1093/eurheartj/ehaf216. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">A global obesity pandemic, coupled with an increasingly ageing population, is exacerbating the burden of cardiovascular disease. Indeed, clinical and experimental evidence underscores a potential connection between obesity and ageing in the pathogenesis of various cardiovascular disorders. This is further supported by the notion that weight reduction not only effectively reduces major cardiovascular events in elderly individuals but is also considered the gold standard for lifespan extension, in obese and non-obese model organisms. This review evaluates the intricate interplay between obesity and ageing from molecular mechanisms to whole organ function within the cardiovascular system. By comparatively analysing their characteristic features, shared molecular and cell biological signatures between obesity and ageing are unveiled, with the intent to shed light on how obesity accelerates cardiovascular ageing. This review also elaborates on how emerging metabolic interventions targeting obesity might protect from cardiovascular diseases largely through antagonizing key molecular mechanisms of the ageing process itself. In sum, this review aims to provide valuable insight into how understanding these interconnected processes could guide the development of novel and effective cardiovascular therapeutics for a growing aged population with a concerning obesity problem.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40197620/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40197620</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf216>10.1093/eurheartj/ehaf216</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40197620</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Celia Ruperez</dc:creator>
<dc:creator>Frank Madeo</dc:creator>
<dc:creator>Rafael de Cabo</dc:creator>
<dc:creator>Guido Kroemer</dc:creator>
<dc:creator>Mahmoud Abdellatif</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Obesity accelerates cardiovascular ageing</dc:title>
<dc:identifier>pmid:40197620</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf216</dc:identifier>
</item>
<item>
<title>A durable competitor or non-starter: is there a role for the biocompatible TiNO stent in acute coronary syndromes?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40197502/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehaf180. doi: 10.1093/eurheartj/ehaf180. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40197502/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40197502</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf180>10.1093/eurheartj/ehaf180</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40197502</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Margaret B McEntegart</dc:creator>
<dc:creator>Anja Oksnes</dc:creator>
<dc:creator>Martin Leon</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A durable competitor or non-starter: is there a role for the biocompatible TiNO stent in acute coronary syndromes?</dc:title>
<dc:identifier>pmid:40197502</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf180</dc:identifier>
</item>
<item>
<title>Gut microbiota as predictors of recurrent cardiovascular events: challenges and future directions</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40197499/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehaf168. doi: 10.1093/eurheartj/ehaf168. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40197499/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40197499</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf168>10.1093/eurheartj/ehaf168</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40197499</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Barbara J H Verhaar</dc:creator>
<dc:creator>Max Nieuwdorp</dc:creator>
<dc:creator>Bert-Jan H van den Born</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Gut microbiota as predictors of recurrent cardiovascular events: challenges and future directions</dc:title>
<dc:identifier>pmid:40197499</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf168</dc:identifier>
</item>
<item>
<title>Post-capillary pulmonary hypertension in heart failure: addressing statistical and methodological issues in research</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40196897/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehae812. doi: 10.1093/eurheartj/ehae812. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40196897/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40196897</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae812>10.1093/eurheartj/ehae812</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40196897</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Guang Xiong</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Post-capillary pulmonary hypertension in heart failure: addressing statistical and methodological issues in research</dc:title>
<dc:identifier>pmid:40196897</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae812</dc:identifier>
</item>
<item>
<title>Cardiovascular disease in chronic kidney disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40196891/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>Individuals with chronic kidney disease (CKD) exhibit an increased risk for the development of cardiovascular disease (CVD) with its manifestations coronary artery disease, stroke, heart failure, arrhythmias, and sudden cardiac death. The presence of both, CVD and CKD has a major impact on the prognosis of patients. This association likely reflects the involvement of several pathophysiological mechanisms, including shared risk factors (e.g. diabetes and hypertension), as well as other factors...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehaf167. doi: 10.1093/eurheartj/ehaf167. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Individuals with chronic kidney disease (CKD) exhibit an increased risk for the development of cardiovascular disease (CVD) with its manifestations coronary artery disease, stroke, heart failure, arrhythmias, and sudden cardiac death. The presence of both, CVD and CKD has a major impact on the prognosis of patients. This association likely reflects the involvement of several pathophysiological mechanisms, including shared risk factors (e.g. diabetes and hypertension), as well as other factors such as inflammation, anaemia, volume overload, and the presence of uraemic toxins. Identifying and characterizing CKD is crucial for appropriate CVD risk prediction. Mitigating CVD risk in patients with CKD mandates a multidisciplinary approach involving cardiologists, nephrologists, and other health care professionals. The present State-of-the-Art Review addresses the current understanding on the pathophysiological link between CVD and CKD, clinical implications and challenges in the treatment of these patients.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40196891/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40196891</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf167>10.1093/eurheartj/ehaf167</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40196891</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Katharina Marx-Schütt</dc:creator>
<dc:creator>David Z I Cherney</dc:creator>
<dc:creator>Joachim Jankowski</dc:creator>
<dc:creator>Kunihiro Matsushita</dc:creator>
<dc:creator>Massimo Nardone</dc:creator>
<dc:creator>Nikolaus Marx</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Cardiovascular disease in chronic kidney disease</dc:title>
<dc:identifier>pmid:40196891</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf167</dc:identifier>
</item>
<item>
<title>Post-capillary Pulmonary Hypertension in Heart Failure is associated with higher mortality and morbidity risk: not just a matter of « hasard »</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40196886/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehae814. doi: 10.1093/eurheartj/ehae814. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40196886/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40196886</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae814>10.1093/eurheartj/ehae814</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40196886</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Charles Fauvel</dc:creator>
<dc:creator>Nicolas Lamblin</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Post-capillary Pulmonary Hypertension in Heart Failure is associated with higher mortality and morbidity risk: not just a matter of « hasard »</dc:title>
<dc:identifier>pmid:40196886</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae814</dc:identifier>
</item>
<item>
<title>Molecular gatekeepers of endogenous adult mammalian cardiomyocyte proliferation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40195566/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>Irreversible cardiac fibrosis, cardiomyocyte death and chronic cardiac dysfunction after myocardial infarction pose a substantial global health-care challenge, with no curative treatments available. To regenerate the injured heart, cardiomyocytes must proliferate to replace lost myocardial tissue - a capability that adult mammals have largely forfeited to adapt to the demanding conditions of life. Using various preclinical models, our understanding of cardiomyocyte proliferation has progressed...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Apr 7. doi: 10.1038/s41569-025-01145-y. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Irreversible cardiac fibrosis, cardiomyocyte death and chronic cardiac dysfunction after myocardial infarction pose a substantial global health-care challenge, with no curative treatments available. To regenerate the injured heart, cardiomyocytes must proliferate to replace lost myocardial tissue - a capability that adult mammals have largely forfeited to adapt to the demanding conditions of life. Using various preclinical models, our understanding of cardiomyocyte proliferation has progressed remarkably, leading to the successful reactivation of cell cycle induction in adult animals, with functional recovery after cardiac injury. Central to this success is the targeting of key pathways and structures that drive cardiomyocyte maturation after birth - nucleation and ploidy, sarcomere structure, developmental signalling, chromatin and epigenetic regulation, the microenvironment and metabolic maturation - forming a complex regulatory framework that allows efficient cellular contraction but restricts cardiomyocyte proliferation. In this Review, we explore the molecular pathways underlying these core mechanisms and how their manipulation can reactivate the cell cycle in cardiomyocytes, potentially contributing to cardiac repair.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40195566/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40195566</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01145-y>10.1038/s41569-025-01145-y</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40195566</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Tim Koopmans</dc:creator>
<dc:creator>Eva van Rooij</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Molecular gatekeepers of endogenous adult mammalian cardiomyocyte proliferation</dc:title>
<dc:identifier>pmid:40195566</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01145-y</dc:identifier>
</item>
<item>
<title>A turning point in cardiac remodelling in obesity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40195565/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Apr 7. doi: 10.1038/s41569-025-01154-x. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40195565/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40195565</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01154-x>10.1038/s41569-025-01154-x</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40195565</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Mariella R Huaman</dc:creator>
<dc:creator>Carlos J Toro-Huamanchumo</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>A turning point in cardiac remodelling in obesity</dc:title>
<dc:identifier>pmid:40195565</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01154-x</dc:identifier>
</item>
<item>
<title>Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193543/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):e921. doi: 10.1161/CIR.0000000000001331. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193543/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40193543</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001331>10.1161/CIR.0000000000001331</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193543</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Jason Hong</dc:creator>
<dc:creator>Lejla Medzikovic</dc:creator>
<dc:creator>Wasila Sun</dc:creator>
<dc:creator>Brenda Wong</dc:creator>
<dc:creator>Grégoire Ruffenach</dc:creator>
<dc:creator>Christopher J Rhodes</dc:creator>
<dc:creator>Adam Brownstein</dc:creator>
<dc:creator>Lloyd L Liang</dc:creator>
<dc:creator>Laila Aryan</dc:creator>
<dc:creator>Min Li</dc:creator>
<dc:creator>Arjun Vadgama</dc:creator>
<dc:creator>Zeyneb Kurt</dc:creator>
<dc:creator>Tae-Hwi Schwantes-An</dc:creator>
<dc:creator>Elizabeth A Mickler</dc:creator>
<dc:creator>Stefan Gräf</dc:creator>
<dc:creator>Mélanie Eyries</dc:creator>
<dc:creator>Katie A Lutz</dc:creator>
<dc:creator>Michael W Pauciulo</dc:creator>
<dc:creator>Richard C Trembath</dc:creator>
<dc:creator>Frédéric Perros</dc:creator>
<dc:creator>David Montani</dc:creator>
<dc:creator>Nicholas W Morrell</dc:creator>
<dc:creator>Florent Soubrier</dc:creator>
<dc:creator>Martin R Wilkins</dc:creator>
<dc:creator>William C Nichols</dc:creator>
<dc:creator>Micheala A Aldred</dc:creator>
<dc:creator>Ankit A Desai</dc:creator>
<dc:creator>David-Alexandre Trégouët</dc:creator>
<dc:creator>Soban Umar</dc:creator>
<dc:creator>Rajan Saggar</dc:creator>
<dc:creator>Richard Channick</dc:creator>
<dc:creator>Rubin M Tuder</dc:creator>
<dc:creator>Mark W Geraci</dc:creator>
<dc:creator>Robert S Stearman</dc:creator>
<dc:creator>Xia Yang</dc:creator>
<dc:creator>Mansoureh Eghbali</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension</dc:title>
<dc:identifier>pmid:40193543</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001331</dc:identifier>
</item>
<item>
<title>Predicting Cardiovascular Risk With Use of Various Tobacco Products</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193542/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):1006-1008. doi: 10.1161/CIRCULATIONAHA.125.073894. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193542/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40193542</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.073894>10.1161/CIRCULATIONAHA.125.073894</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193542</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Neal L Benowitz</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Predicting Cardiovascular Risk With Use of Various Tobacco Products</dc:title>
<dc:identifier>pmid:40193542</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.073894</dc:identifier>
</item>
<item>
<title>Correction to: Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health: A Presidential Advisory From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193541/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):e919. doi: 10.1161/CIR.0000000000001327. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193541/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40193541</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001327>10.1161/CIR.0000000000001327</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193541</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Joseph C Wu</dc:creator>
<dc:creator>Donna K Arnett</dc:creator>
<dc:creator>Ivor J Benjamin</dc:creator>
<dc:creator>Mark A Creager</dc:creator>
<dc:creator>Robert A Harrington</dc:creator>
<dc:creator>Joseph A Hill</dc:creator>
<dc:creator>P Michael Ho</dc:creator>
<dc:creator>Steven R Houser</dc:creator>
<dc:creator>Stephanie Scarmo</dc:creator>
<dc:creator>Svati H Shah</dc:creator>
<dc:creator>Gordon F Tomaselli</dc:creator>
<dc:creator>American Heart Association</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health: A Presidential Advisory From the American Heart Association</dc:title>
<dc:identifier>pmid:40193541</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001327</dc:identifier>
</item>
<item>
<title>Natriuretic Peptides for the Diagnosis of Heart Failure With Preserved Ejection Fraction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193540/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):990-992. doi: 10.1161/CIRCULATIONAHA.125.073788. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193540/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40193540</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.073788>10.1161/CIRCULATIONAHA.125.073788</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193540</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Torbjørn Omland</dc:creator>
<dc:creator>Nicholas L Mills</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Natriuretic Peptides for the Diagnosis of Heart Failure With Preserved Ejection Fraction</dc:title>
<dc:identifier>pmid:40193540</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.073788</dc:identifier>
</item>
<item>
<title>Correction to: Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193539/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):e920. doi: 10.1161/CIR.0000000000001332. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193539/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40193539</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001332>10.1161/CIR.0000000000001332</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193539</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Sheng Zhang</dc:creator>
<dc:creator>Yunkai Zhang</dc:creator>
<dc:creator>Xuewen Duan</dc:creator>
<dc:creator>Bo Wang</dc:creator>
<dc:creator>Zhenzhen Zhan</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism</dc:title>
<dc:identifier>pmid:40193539</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001332</dc:identifier>
</item>
<item>
<title>Correction to: Differential Associations of Cigar, Pipe, and Smokeless Tobacco Use Versus Combustible Cigarette Use With Subclinical Markers of Inflammation, Thrombosis, and Atherosclerosis: The Cross-Cohort Collaboration-Tobacco Working Group</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193538/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250409061434&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):e922. doi: 10.1161/CIR.0000000000001322. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193538/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250409061434&v=2.18.0.post9+e462414">40193538</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001322>10.1161/CIR.0000000000001322</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193538</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Zhiqi Yao</dc:creator>
<dc:creator>Erfan Tasdighi</dc:creator>
<dc:creator>Zeina A Dardari</dc:creator>
<dc:creator>Kunal K Jha</dc:creator>
<dc:creator>Ngozi Osuji</dc:creator>
<dc:creator>Tanuja Rajan</dc:creator>
<dc:creator>Ellen Boakye</dc:creator>
<dc:creator>Carlos J Rodriguez</dc:creator>
<dc:creator>Kunihiro Matsushita</dc:creator>
<dc:creator>Eleanor M Simonsick</dc:creator>
<dc:creator>Joao A C Lima</dc:creator>
<dc:creator>Rachel Widome</dc:creator>
<dc:creator>Debbie L Cohen</dc:creator>
<dc:creator>Lawrence J Appel</dc:creator>
<dc:creator>Amit Khera</dc:creator>
<dc:creator>Michael E Hall</dc:creator>
<dc:creator>Suzanne Judd</dc:creator>
<dc:creator>Shelley A Cole</dc:creator>
<dc:creator>Ramachandran S Vasan</dc:creator>
<dc:creator>Emelia J Benjamin</dc:creator>
<dc:creator>Aruni Bhatnagar</dc:creator>
<dc:creator>Andrew P DeFilippis</dc:creator>
<dc:creator>Michael J Blaha</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Differential Associations of Cigar, Pipe, and Smokeless Tobacco Use Versus Combustible Cigarette Use With Subclinical Markers of Inflammation, Thrombosis, and Atherosclerosis: The Cross-Cohort Collaboration-Tobacco Working Group</dc:title>
<dc:identifier>pmid:40193538</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001322</dc:identifier>
</item>





























</channel>
</rss>